Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine.

Saved in:
Bibliographic Details
Title: Efficacy, Immunogenicity, and Safety of an Investigational Maternal Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine.
Authors: Banooni P; Matrix Clinical Research, Los Angeles, California, USA., Gonik B; Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA., Epalza C; Department of Pediatrics, Pediatric Infectious Diseases Unit, Hospital Universitario 12 de Octubre, Madrid, Spain.; Fundación Biomédica Investigación Hospital 12 Octubre, Madrid, Spain., Reyes O; Centro de Vacunación e Investigación, Panama City, Panama.; Sistema Nacional de Investigación, Panama City, Panama., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Gomez-Go GD; Department of Pediatrics, Mary Chiles General Hospital, Manila, Philippines., Zaman K; Matlab Health Research Centre, International Centre for Diarrheal Disease Research, Dhaka, Bangladesh., Llapur CJ; Instituto de Maternidad y Ginecología Nuestra Señora de las Mercedes, Tucumán, Argentina., López-Medina E; Department of Pediatrics, Centro de Estudios de Infectología Pediátrica, Universidad del Valle Clínica Imbanaco Grupo Quironsalud, Cali, Colombia., Stanley T; Paediatrics & Child Health, Wellington Regional Hospital and University of Otago, Wellington, New Zealand., Kantele A; Department of Medicine, Meilahti Vaccine Research Center, Helsinki University and Helsinki University Hospital, Helsinki, Finland., Huang LM; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan., Mussi-Pinhata MM; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Dewulf J; Department of Pediatrics, AZ Groeninge Hospital, Kortrijk, Belgium., Langley JM; Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada.; Canadian Center for Vaccinology, IWK Health Centre, Halifax, Nova Scotia, Canada.; Nova Scotia Health, Halifax, Nova Scotia, Canada., Seidl C; GSK, Munich, Germany., Ota M; GSK, Rixensart, Belgium., Kirabo M; GSK, Wavre, Belgium., Anspach B; GSK, Rockville, Maryland, USA., Dieussaert I; GSK, Wavre, Belgium., Henry O; GSK, Rockville, Maryland, USA., Kim JH; GSK, Rockville, Maryland, USA., Picciolato M; GSK, Wavre, Belgium.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 09; Vol. 82 (1), pp. e146-e155.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaf033